SHEIBAN, Imad
 Distribuzione geografica
Continente #
NA - Nord America 3.115
EU - Europa 1.728
AS - Asia 1.151
SA - Sud America 15
AF - Africa 9
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.025
Nazione #
US - Stati Uniti d'America 3.070
CN - Cina 537
SG - Singapore 319
IE - Irlanda 314
IT - Italia 281
SE - Svezia 275
FI - Finlandia 177
UA - Ucraina 157
KR - Corea 139
DE - Germania 128
FR - Francia 126
AT - Austria 97
PL - Polonia 68
GB - Regno Unito 50
CA - Canada 43
VN - Vietnam 41
IN - India 40
JP - Giappone 27
BE - Belgio 12
ID - Indonesia 11
BR - Brasile 10
RU - Federazione Russa 10
HK - Hong Kong 7
NL - Olanda 7
TR - Turchia 7
GR - Grecia 5
MU - Mauritius 4
NO - Norvegia 4
UZ - Uzbekistan 4
AU - Australia 3
BG - Bulgaria 3
DK - Danimarca 3
ES - Italia 3
EU - Europa 3
SN - Senegal 3
BD - Bangladesh 2
CH - Svizzera 2
EC - Ecuador 2
IL - Israele 2
KH - Cambogia 2
PE - Perù 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 6.025
Città #
Chandler 427
Beijing 398
Santa Clara 324
Dublin 313
Singapore 271
Houston 163
Ann Arbor 154
Torino 120
Medford 110
Jacksonville 97
Princeton 97
Vienna 97
Fairfield 94
Wilmington 84
Villeurbanne 81
Dearborn 79
Nyköping 79
Columbus 77
Ashburn 72
Warsaw 65
Fremont 47
Seattle 39
New York 31
Pavia 31
Toronto 29
Woodbridge 28
Cambridge 27
Redwood City 27
Dong Ket 26
Boston 19
Guangzhou 17
Helsinki 17
Boardman 16
Pisa 16
Falls Church 15
Milan 14
Nanjing 14
Shanghai 14
Duncan 13
Düsseldorf 13
Hefei 13
Norwalk 13
Brussels 12
Buffalo 12
Los Angeles 12
Rome 11
Detroit 10
Jakarta 9
Kunming 9
Tokyo 9
Jinan 8
Turin 7
Paris 6
Pune 6
San Diego 6
Washington 6
Chengdu 5
Hong Kong 5
Kolkata 5
San Mateo 5
Tappahannock 5
Appiano Gentile 4
Dallas 4
Florence 4
Fuzhou 4
Kharkiv 4
Montreal 4
Mountain View 4
Redmond 4
Verona 4
West Jordan 4
Baotou 3
Falkenstein 3
Fossano 3
Genova 3
Hangzhou 3
Lachine 3
London 3
Munich 3
New Delhi 3
Riverton 3
San Maurizio Canavese 3
Shenyang 3
Silver Spring 3
Stavanger 3
Zhengzhou 3
Amsterdam 2
Atatürk 2
Bandung 2
Canberra 2
Cape Coral 2
Changsha 2
Chicago 2
Clearwater 2
Copenhagen 2
Dhaka 2
Gothenburg 2
Guayaquil 2
Hadera 2
Istanbul 2
Totale 3.942
Nome #
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries 195
Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries 181
30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter study. 178
Intramural left atrial hematoma: A complication of primary coronary angioplasty inferior myocardial infarction 171
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes 160
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 140
Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrix 103
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 102
Impact of multivessel coronary disease on long-term outcome after percutaneous recanalization of coronary chronic total occlusions 101
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 100
Percutaneous drug-eluting stent implantation in diabetic patients: short and long term outcomes from an observational study. 89
Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. 89
Homing of Annexin-labeled stem cells to apoptotic cells 88
Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial Infarction 88
In vivo coronary plaque histology in patients with stable and acute coronary syndromes. Relationships with hyperlipidemic status and statin treatment 86
Telecardiogram: still of matter in the modern cardiac imaging era? 85
Impact of TAVI on Mitral Regurgitation: A Prospective Echocardiographic Study 85
Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry. 85
Gender differences in patients undergoing TAVI: a multicentre study. 83
Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary interventions 80
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations 79
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study) 79
Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression 76
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. 76
Safety of coronary collateral stenting in a patient with acute coronary syndrome 76
Efficacy of a novel anti-inflammatory drug-eluting balloon coated with genistein before stent implantation in porcine coronary arteries 75
Cateterismo cardiaco transettale 75
Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: A dangerous duo? 74
Impact of Kissing Balloon in Patients Treated with Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis from the RAIN-CARDIOGROUP VII Study 74
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 73
A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions 71
[Left main coronary artery stenosis]. 71
Alterazioni elettrocardiografiche post-TAVI in acuto. 71
Long-term (≥10 years) safety of percutaneous treatment of unprotected left main stenosis with drug-eluting stents 71
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease 68
Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients 68
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life) 68
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting. 67
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. 66
Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). 65
Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions 65
Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials 65
Percutaneous coronary intervention on left main coronary artery trifurcation 64
Short and long-term outcomes of percutaneous revascularization in patients with prior coronary artery bypass graft. 64
Repeat adverse events long after percutaneous coronary revascularization in diabetics 64
Volatile anesthetics reduce mortality in cardiac surgery. 63
Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. 63
Antithrombotic strategies following coronary artery stenting in patients on oral anticoagulation for atrial fibrillation 61
Coronary thrombosis in a patient with leukemic thrombocytosis: which was the best treatment? 60
Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. 60
Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. 60
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study 60
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. 60
Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. 58
Quantitative coronary angiography in the current era: principles and applications. 58
Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn? 57
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). 54
Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? 54
Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. 54
Very long-term follow-up of conservative vs invasive strategies for unstable angina and non-ST Segment Elevation Myocardial Infarction 53
Systematic reviews and meta-analyses "For Dummies". 52
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial 51
Very long-term follow-up of conservative vs invasive strategies for stable angina 51
Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease 50
Diagnosis and treatment of patent foramen ovale patency after percutaneous closure 49
Percutaneous aortic valve replacement in two cases at high surgical risk: procedural details and implications for patient selection. 49
Letter regarding article by Solomon et al, "Cardiac Angiography inREnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease 48
Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure. 47
[Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery]. 45
[Percutaneous transluminal angioplasty: synonymous of quality of life?]. 43
Postpartum valve thrombosis: a happy ending thriller. 43
Myocardial viability after primary coronary angioplasty: low-dose dobutamine stress echocardiography versus myocardial contrast echocardiography 43
Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. 42
Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year. 42
Update on dedicated bifurcation stents. 42
Evolution of conduction disturbances following transcatheter aortic valve implantation over one year follow up 41
Long-term effect of chronic oral anticoagulation: focus on coronary artery disease. 40
Letter by Bollati et al regarding article, "Off-pump versus on-pumpcoronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization" 40
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry. 39
Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY. 39
Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty. 39
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. 38
Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. 37
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. 37
Iatrogenic coronary-to-right ventricle fistula: benign outcome irrespective of patency? 36
Last nail in the coffin of late lumen loss? 36
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. 35
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronaryintervention 34
Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. 33
International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. 30
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms 29
RAPSTROM™ first-in-man study long-term results of a biodegradable polymer sustained-release sirolimus-eluting stent in de novo coronary stenoses 29
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry) 20
Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study 10
Totale 6.268
Categoria #
all - tutte 20.936
article - articoli 0
book - libri 0
conference - conferenze 1.257
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020471 0 0 0 0 0 141 102 32 39 83 52 22
2020/2021631 62 45 60 24 73 30 89 37 58 53 36 64
2021/2022727 12 12 20 49 30 33 55 44 19 55 192 206
2022/20231.155 128 76 28 119 115 333 105 59 102 17 59 14
2023/2024531 88 97 32 50 50 54 9 18 9 21 33 70
2024/2025882 6 179 58 158 320 161 0 0 0 0 0 0
Totale 6.268